{"id":"doi:10.1038/s41571-020-00460-2","kind":"review","title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","authors":["Eryn Blass","Patrick Alexander Ott"],"author_count":2,"year":2021,"published":"2021-01-20","venue":"Nature Reviews Clinical Oncology","cited_by":1035,"doi":"10.1038/s41571-020-00460-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41571-020-00460-2","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41571-020-00460-2","updated":null,"pmid":"33473220","pmcid":null,"openalex_id":"W3124720941","pdf_url":"https://www.nature.com/articles/s41571-020-00460-2.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Immunotherapy and Immune Responses"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}